ÜREMİŞ, M. M. Et Al. 2022. Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways. CURRENT CANCER DRUG TARGETS , vol.22, no.11 , 931-944.

ÜREMİŞ, M. M., ÜREMİŞ, N., TOSUN, E., Durhan, M., ÇİĞREMİŞ, Y., BAYSAR, A., ... TÜRKÖZ, Y.(2022). Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways. CURRENT CANCER DRUG TARGETS , vol.22, no.11, 931-944.

ÜREMİŞ, MUHAMMED Et Al. "Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways," CURRENT CANCER DRUG TARGETS , vol.22, no.11, 931-944, 2022

ÜREMİŞ, MUHAMMED M. Et Al. "Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways." CURRENT CANCER DRUG TARGETS , vol.22, no.11, pp.931-944, 2022

ÜREMİŞ, M. M. Et Al. (2022) . "Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways." CURRENT CANCER DRUG TARGETS , vol.22, no.11, pp.931-944.

@article{article, author={MUHAMMED MEHDİ ÜREMİŞ Et Al. }, title={Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways}, journal={CURRENT CANCER DRUG TARGETS}, year=2022, pages={931-944} }